Erratum: Efficacy and Safety of Camrelizumab Plus Apatinib in Patients With Refractory Chordoma: A Phase II Clinical Trial

Cheng Yang

Institute of Materials Research

Qi Jia

Chenglong Zhao

Department of Radiation Science and Technology

Xinghai Yang

The Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China

Haifeng Wei

The Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China

Tielong Liu

The Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China

Jian Jiao

Zhipeng Wu

Earth and Climate Research Center, Earth and Life Institute, Université catholique de Louvain

Jian Zhao

Wei Xu

Zhenhua Zhou

Wei Wan

MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry

Weiwei Zou

Zhi Zhu

State Key Laboratory of Physical Chemistry of Solid Surfaces, Key Laboratory for Chemical Biology of Fujian Province, The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, Department of Chemical Biology, College of Chemistry and Chemical Engineering, State Key Laboratory of Vaccines for Infectious Diseases, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, School of Life Sciences, Faculty of Medicine and Life Sciences

Xiaomei Ma

Qi Chen

Wei Guo

Dongqing Zhu

The Department of Radiology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China

Tao Tan

Yan Lou

Juelan Ye

The Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China

Jingyu Xing

The Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China

Hao Zhang

Zijie Yuan

The Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China

Jianru Xiao

The Department of Orthopedic Oncology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China